相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients
Shamir N. Kalaria et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Time above the MIC of Piperacillin-Tazobactam as a Predictor of Outcome in Pseudomonas aeruginosa Bacteremia
Elias Tannous et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia
Noriyuki Ishihara et al.
ANTIBIOTICS-BASEL (2020)
Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis
Lisa Ehmann et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and Children
Celine Thibault et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Population Pharmacokinetics of Piperacillin in Sepsis Patients: Should Alternative Dosing Strategies Be Considered?
Maria Goul Andersen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis
Nathaniel J. Rhodes et al.
CRITICAL CARE MEDICINE (2018)
Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials
Konstantinos Z. Vardakas et al.
LANCET INFECTIOUS DISEASES (2018)
A Regression Approach to Visual Predictive Checks for Population Pharmacometric Models
Kris M. Jamsen et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Antimicrobial Pharmacokinetics and Pharmacodynamics in Older Adults
John M. Benson
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2017)
Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling
Phillip J. Bergen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Fluconazole Population Pharmacokinetics and Dosing for Prevention and Treatment of Invasive Candidiasis in Children Supported with Extracorporeal Membrane Oxygenation
Kevin M. Watt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Longitudinal Study of the Decline in Renal Function in Healthy Subjects
Mika Baba et al.
PLOS ONE (2015)
Phamiacologic studies in vulnerable populations: Using the pediatric experience
Kanecia Zimmerman et al.
SEMINARS IN PERINATOLOGY (2015)
Clinical Outcomes with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Systematic Review and Meta-Analysis
Hui Yang et al.
PLOS ONE (2015)
Impact of Loading Doses on the Time to Adequate Predicted Beta-Lactam Concentrations in Prolonged and Continuous Infusion Dosing Schemes
Nathaniel J. Rhodes et al.
CLINICAL INFECTIOUS DISEASES (2014)
Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia
Fumi Karino et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Under-representation of older adults in pharmacokinetic and pharmacodynamic studies: a solvable problem?
Arduino A. Mangoni et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
Population Pharmacokinetics of Piperacillin at Two Dose Levels: Influence of Nonlinear Pharmacokinetics on the Pharmacodynamic Profile
Cornelia B. Landersdorfer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections
T. W. Felton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Population Pharmacokinetics of Piperacillin Using Scavenged Samples From Preterm Infants
Michael Cohen-Wolkowiez et al.
THERAPEUTIC DRUG MONITORING (2012)
Pitfalls in the Diagnosis and Therapy of Infections in Elderly Patients - A Mini-Review
Rosa Bellmann-Weiler et al.
GERONTOLOGY (2009)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore
Paul G. Ambrose et al.
CLINICAL INFECTIOUS DISEASES (2007)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
A global clinical measure of fitness and frailty in elderly people
K Rockwood et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update
JW Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers
WA Krueger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
AA Mangoni et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Measured and estimated GFR in healthy potential kidney donors
AD Rule et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
分享论文
